Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 178 participants.

Also called NCT02661451

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 178 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02661451
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada, Netherlands (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT02661451. Randomized; no masking; primary purpose treatment. Start 2016-09 (actual); primary completion 2023-02-28 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
Condition
Aortic Valve Stenosis
Intervention (Device)
SAPIEN 3 THV
Intervention (Biological)
Optimal Heart Failure Therapy
Lead sponsor
Cardiovascular Research Foundation, New York (class: other)
Collaborator
Cardialysis BV (class: industry)
Collaborator
Avania (class: industry)

Record details

Record id
cardio:ct-nct02661451
Content hash
774f4d31a49a2fcca419e96be6d950df346526b406e7806561b3d9aceeecf029